Patent Yard Sign in
Canadian application, no grantCanada

2'-substituted nucleosides and oligonucleotide derivatives

CA 2256765 A1 · Owner: Altmann, Karl-Heinz · Inventors: Moser, Heinz Ernst; Altmann, Karl-Heinz; Martin, Pierre

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention relates to an oligonucleotide derivative which comprises at least one nucleoside building block of the formula (I). The invention furthermore relates to nucleoside building blocks intermediates and processes , for preparing the oligonucleotide derivatives and the nucleoside building blocks. The invention also relates to pharmaceutical compositions and to uses of the oligonucleotide derivatives and the nucleoside building blocks.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 27, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 27, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 27, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 27, 1997
GrantedNo grant recorded
Term endedMay 27, 2017
Patent numberCA 2256765 A1
Classification (IPC)C07H21/00 +2 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedMay 27, 1997Term endedMay 27, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.